<\/p>\n
NEW FILINGS<\/strong><\/span><\/p>\n Company: Revolution Medicines, Inc. Company: Fathom Holdings TERMS ADDED<\/strong><\/span><\/p>\n Company: Avadim Health Inc. Company: 1Life Healthcare, Inc. Company: Reynolds Consumer Products, Inc. Company: Black Diamond Therapeutics, Inc. Company: Arcutis Biotherapeutics Inc.
\nSymbol: RVMD
\nDescription: They are a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, high-value frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): JP Morgan, Cowen, SVB Leerink, Guggenheim
\nFiled: 1-17-20
\nListed Cash Raise: $100m<\/p>\n
\nSymbol: FTHM
\nDescription: They are a cloud-based, technology-driven real estate brokerage company.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Roth Capital
\nFiled: 1-17-20
\nListed Cash Raise: $14m<\/p>\n
\nSymbol: AHI
\nDescription: They are a high-growth, healthcare and wellness company that sells topical products to improve immune health, neuromuscular health and skin barrier health.
\nShares: 5 million
\nPrice Range: $14.00-$16.00
\nMarket Cap: $321m-$367m
\nTrade Date: Thursday, 1\/30
\nUnderwriter(s): Raymond James, SunTrust Robinson Humphrey
\nCo-Manager(s): Oppenheimer
\nTerms Added: 1-17-20<\/p>\n
\nSymbol: ONEM
\nDescription: They are a membership-based primary care platform with seamless digital health and inviting in-office care, convenient to where people work, shop, live and click.
\nShares: 17.5 million
\nPrice Range: $14.00-$16.00
\nMarket Cap: $1.7b-$1.96b
\nTrade Date: Friday, 1\/31
\nUnderwriter(s): JP Morgan, Morgan Stanley
\nCo-Manager(s): Allen & Co., Citigroup, Piper Jaffray, Wells Fargo, William Blair, Baird, SunTrust Robinson Humphrey
\nTerms Added: 1-21-20<\/p>\n
\nSymbol: REYN
\nDescription: They are a market-leading consumer products company with a presence in 95% of households across the United States.
\nShares: 47.17 million
\nPrice Range: $25.00-$28.00
\nMarket Cap: $5.1b-5.7b
\nTrade Date: Friday, 1\/31
\nUnderwriter(s): Credit Suisse, Goldman Sachs, JP Morgan, Barclays, Citigroup, Evercore ISI, RB
\nCo-Manager(s): HSBC, Stifel, SunTrust Robinson
\nTerms Added: 1-21-20<\/p>\n
\nSymbol: BDTX
\nDescription: They are a precision oncology medicine company pioneering the discovery and development of small molecule, tumor-agnostic therapies.
\nShares: 8.9 million
\nPrice Range: $16.00-$18.00
\nMarket Cap: $520m-$590m
\nTrade Date: Thursday, 1\/30
\nUnderwriter(s): JP Morgan, Jefferies, Cowen
\nCo-Manager(s): Canaccord Genuity
\nTerms Added: 1-21-20<\/p>\n
\nSymbol: ARQT
\nDescription: They are a late-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs.
\nShares: 7.8 million ADSs
\nPrice Range: $15.00-$17.00
\nMarket Cap: $530m-$600m
\nTrade Date: Friday, 1\/31
\nUnderwriter(s): Goldman Sachs, Cowen, Guggenheim Securities
\nCo-Manager: Cantor
\nTerms Added 1-21-20<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24,1536],"tags":[],"class_list":["post-11413","post","type-post","status-publish","format-standard","hentry","category-ipo","category-subscriber-content"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/11413","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=11413"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/11413\/revisions"}],"predecessor-version":[{"id":11414,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/11413\/revisions\/11414"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=11413"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=11413"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=11413"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}